Skip to main content

Table 4 Results of node-splitting analysis

From: Optimal drug regimens for improving ALP biochemical levels in patients with primary biliary cholangitis refractory to UDCA: a systematic review and Bayesian network meta-analysis

Comparison

p value

bezafibrate + UDCA/fenofibrate + UDCA

0.08

bezafibrate + UDCA/UDCA

0.07

fenofibrate + UDCA/UDCA

0.08